QuidelOrtho Statistics
Total Valuation
QuidelOrtho has a market cap or net worth of $2.10 billion. The enterprise value is $4.61 billion.
| Market Cap | 2.10B |
| Enterprise Value | 4.61B |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
QuidelOrtho has 66.97 million shares outstanding. The number of shares has decreased by -0.30% in one year.
| Shares Outstanding | 66.97M |
| Shares Change (YoY) | -0.30% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 1.43% |
| Owned by Institutions (%) | 97.40% |
| Float | 51.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 12.69 |
| PS Ratio | 0.73 |
| Forward PS | 0.75 |
| PB Ratio | 0.63 |
| P/FCF Ratio | n/a |
| PEG Ratio | 7.19 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.78.
| Current Ratio | 1.56 |
| Quick Ratio | 0.45 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.60 |
Financial Efficiency
Return on equity (ROE) is -38.60% and return on invested capital (ROIC) is -29.17%.
| Return on Equity (ROE) | -38.60% |
| Return on Assets (ROA) | -21.80% |
| Return on Capital (ROIC) | -29.17% |
| Revenue Per Employee | $403,197 |
| Profits Per Employee | -$248,577 |
| Employee Count | 7,100 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 2.67 |
Taxes
| Income Tax | -123.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.33% in the last 52 weeks. The beta is 0.12, so QuidelOrtho's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | -62.33% |
| 50-Day Moving Average | 40.16 |
| 200-Day Moving Average | 56.29 |
| Relative Strength Index (RSI) | 22.13 |
| Average Volume (20 Days) | 946,475 |
Short Selling Information
The latest short interest is 2.96 million, so 4.42% of the outstanding shares have been sold short.
| Short Interest | 2.96M |
| Short Previous Month | 2.91M |
| Short % of Shares Out | 4.42% |
| Short % of Float | 5.74% |
| Short Ratio (days to cover) | 3.22 |
Income Statement
In the last 12 months, QuidelOrtho had revenue of $2.86 billion and -$1.76 billion in losses. Loss per share was -$26.38.
| Revenue | 2.86B |
| Gross Profit | 1.38B |
| Operating Income | -1.72B |
| Pretax Income | -1.89B |
| Net Income | -1.76B |
| EBITDA | -1.28B |
| EBIT | -1.74B |
| Loss Per Share | -$26.38 |
Balance Sheet
The company has $78.50 million in cash and $2.58 billion in debt, giving a net cash position of -$2.51 billion or -$37.41 per share.
| Cash & Cash Equivalents | 78.50M |
| Total Debt | 2.58B |
| Net Cash | -2.51B |
| Net Cash Per Share | -$37.41 |
| Equity (Book Value) | 3.31B |
| Book Value Per Share | 49.39 |
| Working Capital | 432.60M |
Cash Flow
In the last 12 months, operating cash flow was $90.60 million and capital expenditures -$196.20 million, giving a free cash flow of -$105.60 million.
| Operating Cash Flow | 90.60M |
| Capital Expenditures | -196.20M |
| Free Cash Flow | -105.60M |
| FCF Per Share | -$1.58 |
Margins
Gross margin is 48.13%, with operating and profit margins of -60.03% and -61.65%.
| Gross Margin | 48.13% |
| Operating Margin | -60.03% |
| Pretax Margin | -65.95% |
| Profit Margin | -61.65% |
| EBITDA Margin | -44.72% |
| EBIT Margin | -60.72% |
| FCF Margin | -3.69% |
Dividends & Yields
QuidelOrtho does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.30% |
| Shareholder Yield | 0.30% |
| Earnings Yield | -84.03% |
| FCF Yield | -5.03% |
Analyst Forecast
The average price target for QuidelOrtho is $59.00, which is 88.14% higher than the current price. The consensus rating is "Hold".
| Price Target | $59.00 |
| Price Target Difference | 88.14% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 0.11% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
QuidelOrtho has an Altman Z-Score of 0.12 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.12 |
| Piotroski F-Score | 3 |